Synergy between the pharmacological chaperone 1-deoxygalactonojirimycin and agalsidase alpha in cultured fibroblasts from patients with Fabry disease

J Inherit Metab Dis. 2014 Jan;37(1):145-6. doi: 10.1007/s10545-013-9641-z. Epub 2013 Aug 22.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • 1-Deoxynojirimycin / analogs & derivatives*
  • Fabry Disease / enzymology*
  • Fabry Disease / metabolism*
  • Fibroblasts / metabolism*
  • Humans
  • Male
  • Recombinant Proteins / metabolism*
  • alpha-Galactosidase / metabolism*

Substances

  • Recombinant Proteins
  • 1-Deoxynojirimycin
  • alpha-Galactosidase